Concepedia

Jérôme Guillemont

JG

Statistics

Publications

30

Citations

4.9K

H-Index

23

Active since

1991

Affiliations

Johnson & Johnson (France)(Current)

Centre National de la Recherche Scientifique

Johnson & Johnson (United States)

Janssen (France)

Janssen (Belgium)

Jérôme Guillemont is an author at Johnson & Johnson (France) specializing in medicine, drug discovery, and biochemistry.

ORCID

Top concepts

Publications per year

1991–2022

30

Publications

30

A Diarylquinoline Drug Active on the ATP Synthase of <i>Mycobacterium tuberculosis</i>

Koen Andries, Peter Verhasselt, Jérôme Guillemont et al. · Science · 2004 · 2.1K citations · Full text

, , +18

Diarylquinolines target subunit c of mycobacterial ATP synthase

Anil Koul, Najoua Dendouga, Karen Vergauwen et al. · Nature Chemical Biology · 2007 · 537 citations · Full text

, , +5

Diarylquinolines Are Bactericidal for Dormant Mycobacteria as a Result of Disturbed ATP Homeostasis

Anil Koul, Luc Vranckx, Najoua Dendouga et al. · Journal of Biological Chemistry · 2008 · 360 citations · Full text

Structure of the mycobacterial ATP synthase F <sub>o</sub> rotor ring in complex with the anti-TB drug bedaquiline

Julian D. Langer, Luise Eckhardt-Strelau, Jérôme Guillemont et al. · Science Advances · 2015 · 281 citations · Full text

, , +13

Selectivity of TMC207 towards Mycobacterial ATP Synthase Compared with That towards the Eukaryotic Homologue

Anna C. Haagsma, Rooda Abdillahi-Ibrahim, Marijke J. Wagner et al. · Antimicrobial Agents and Chemotherapy · 2008 · 218 citations · Full text

1–5 of 30